KEYNOTE-407: 5-Year Update of Pembrolizumab Plus Chemotherapy for Squamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
J. Clin. Oncol 2023 Feb 03;[EPub Ahead of Print], S Novello, DM Kowalski, A Luft, M Gümüş, D Vicente, J Mazières, J Rodríguez-Cid, A Tafreshi, Y Cheng, KH Lee, A Golf, S Sugawara, AG Robinson, B Halmos, E Jensen, P Schwarzenberger, MC Pietanza, L Paz-AresFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.